The aforementioned data led us to hypothesize that miR-624 may play a key role in promoting chemotherapy resistance of ESCC cells by regulating the ARRDC3/YAP/HIF1α signaling axis. The gene discussed is ARRDC3; the disease is esophageal squamous cell carcinoma.